ReHuman System is a longevity institution building a small, considered system of botanical and clinical formulas — for cellular vitality, resilience, and the long arc of human performance.
Biology, intelligence, energy, and environment, considered as one continuum. ReHuman System is built around four steady pillars — the foundation for everything we formulate, study, and recommend.
Designing for the long arc vitality measured in decades, not weeks.
Supporting the body's own repair systems — through botanical and cellular pathways.
Compounds at the dose where evidence begins — not the dose where marketing ends.
Calibrating biology, behavior, and environment — to a coherent rhythm.
Three opening formulas, each built around a single well-studied compound at clinical dose. Matte-black apothecary jars, considered for the long horizon.
Three opening formulas, each built around a single well-studied compound at clinical dose. Step through Lixir, Bio, and Optima.
ReHuman System is not a launch — it is an institution. We move in stages, each one earning the credibility for the next.
Foundational formulas for vitality, resilience, recovery, and cognitive clarity.
A personalization engine — biomarker analysis and adaptive recommendations as a technical moat.
An institute-grade research arm — pathways, observational studies, and cellular rejuvenation work.
Each compound in the ReHuman system is documented, sourced, and characterized — a quiet refusal of the supplement industry's casualness. Third-party tested, batch by batch.
A handful of members from the Phase 01 cohort. Each completed the full protocol with lab work taken before and after — these are their own words.
I came in skeptical — I have a drawer of half-finished bottles to prove it. Six weeks in, my afternoon crash is gone and my morning resting heart rate dropped four points. Nothing dramatic. Just the kind of compounding small wins I usually only see from sleep.
I’ve recommended longevity protocols to patients for fifteen years and I’m unusually careful about what I take myself. The formulation is restrained in the right places — no kitchen-sink stack, no inflated dosages — and the third-party assays match the label. That alone is rare.
My VO₂ max stopped climbing at 47 — for two years. After one cycle of Bio, my lab pulled a three-point gain and a meaningful drop in hs-CRP. I train with a coach who reads bloodwork; he asked what I changed. This was the only thing.
We are not selling supplements.
We are designing the quiet infrastructure of a longer, more intelligent human life.
A collection of writing from the ReHuman System — on longevity, formulation, measurement, and the long arc of human performance.
Three billion dollars into Altos Labs. Calico working in near-silence for over a decade. Loyal running drug trials in dogs. Bryan Johnson publishing his bloodwork in public. A field that used to live at the edges of biology has moved into the center of serious science and serious capital — but most people haven’t noticed yet. What’s actually changing, who is doing the real work, and which questions remain genuinely open.
Read →The standard move in this industry is the kitchen-sink stack: twelve compounds in a morning capsule, nine more at night, a list of brand names so long it stops meaning anything. We do the opposite — and the reason isn’t minimalism for its own sake. Every well-studied longevity compound has a dose where the evidence begins, and a dose where the evidence ends. The case for restraint, and what gets lost when a formulation tries to do everything at once.
Read →The line that separates the longevity space from the wellness space is measurement. Fasting insulin. hs-CRP. Apolipoprotein B. HbA1c. VO₂ max as a number, not a feeling. A protocol that improves these markers over six months is a real protocol; one that doesn’t is a story you’re telling yourself. How to think about baseline lab work, what to actually test for, and why “I feel better” is the least reliable answer.
Read →For most of the modern era, the contract was simple: work, age, retire into decline. That’s changing. A generation is no longer asking how to extend the end of life — they’re asking how to be at fifty-five the person they were at thirty-five. The cultural shift toward healthspan over lifespan, why a product like ours can exist now when it couldn’t a decade ago, and the audience the longevity industry is actually serving.
Read →The system opens in measured batches. Request access to receive the next release, protocol notes, and early research from the lab.
